Escorsell Àngels, Castellote José, Sánchez-Delgado Jordi, Charco Ramon, Crespo Gonzalo, Fernández Javier
UCI-IMDM, Servei d'Hepatologia, Hospital Clínic, Barcelona, España; IDIBAPS, Universitat de Barcelona, Barcelona, España; CIBERehd, Instituto de Salud Carlos III, Madrid, España.
IDIBAPS, Universitat de Barcelona, Barcelona, España; CIBERehd, Instituto de Salud Carlos III, Madrid, España; Hepatologia i Unitat de Trasplantament Hepàtic, Servei d'Aparell Digestiu, Hospital Universitari de Bellvitge, l'Hospitalet del Llobregat, España.
Gastroenterol Hepatol. 2019 Jan;42(1):51-64. doi: 10.1016/j.gastrohep.2018.07.013. Epub 2018 Oct 8.
Acute liver failure is an uncommon and severe disease characterised by a rapid onset of severe hepatocellular failure in individuals without previous liver disease. Initial management of this entity determines the outcome of the patient. Initial contact with the acute liver failure patients usually occurs in the emergency department, digestology clinic or, in more severe cases, intensive care units. The management of acute liver failure patients in all these cases must be multidisciplinary, involving surgeons and hepatologists who are experts in this condition, meaning those from hospitals with active liver transplant programmes. This article reviews the current body of evidence concerning the medical management of acute liver failure patients, from the suspected diagnosis and initial management to intensive medical treatment, including the need for an emergency liver transplantation. Moreover, we also review the use of artificial liver support systems in this setting.
急性肝衰竭是一种罕见的严重疾病,其特征是既往无肝病的个体迅速出现严重的肝细胞功能衰竭。对该疾病的初始管理决定了患者的预后。与急性肝衰竭患者的初次接触通常发生在急诊科、消化科门诊,在更严重的情况下,会在重症监护病房。在所有这些情况下,急性肝衰竭患者的管理必须是多学科的,需要活跃开展肝移植项目的医院中擅长此疾病的外科医生和肝病专家参与。本文回顾了有关急性肝衰竭患者药物治疗的现有证据,从疑似诊断和初始管理到强化药物治疗,包括紧急肝移植的必要性。此外,我们还回顾了在这种情况下人工肝支持系统的应用。